167 related articles for article (PubMed ID: 18446403)
41. Genetic influence of hormone-replacement therapy on venous thromboembolism.
Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
[No Abstract] [Full Text] [Related]
42. Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
Shafi S; Samad Z; Syed S; Sharif A; Khan MA; Nehal US; Siddiqui AR
J Pak Med Assoc; 2001 Dec; 51(12):450-3. PubMed ID: 11850984
[TBL] [Abstract][Full Text] [Related]
43. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
Rexrode KM; Manson JE
Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
[No Abstract] [Full Text] [Related]
44. Survey of the use of homeopathic medicine in the UK health system.
Swayne JM
J R Coll Gen Pract; 1989 Dec; 39(329):503-6. PubMed ID: 2558206
[TBL] [Abstract][Full Text] [Related]
45. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
Bounameaux H; de Moerloose P; Campana A
Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
[TBL] [Abstract][Full Text] [Related]
46. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
47. Variations in Burn Excision and Grafting: A Survey of the American Burn Association.
Israel JS; Greenhalgh DG; Gibson AL
J Burn Care Res; 2017; 38(1):e125-e132. PubMed ID: 27893575
[TBL] [Abstract][Full Text] [Related]
48. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.
Huerta C; Johansson S; Wallander MA; García Rodríguez LA
Arch Intern Med; 2007 May; 167(9):935-43. PubMed ID: 17502535
[TBL] [Abstract][Full Text] [Related]
49. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
[TBL] [Abstract][Full Text] [Related]
50. What do plastic surgeons do?
Park AJ; Scerri GV; Benamore R; McDiarmid JG; Lamberty BG
J R Coll Surg Edinb; 1998 Jun; 43(3):189-93. PubMed ID: 9654882
[TBL] [Abstract][Full Text] [Related]
51. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
52. Differences in treatment of Spitz nevi and atypical Spitz tumors in pediatric patients among dermatologists and plastic surgeons.
Metzger AT; Kane AA; Bayliss SJ
JAMA Dermatol; 2013 Nov; 149(11):1348-50. PubMed ID: 24026360
[No Abstract] [Full Text] [Related]
53. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Scarabin PY; Oger E; Plu-Bureau G;
Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
[TBL] [Abstract][Full Text] [Related]
54. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM
BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043
[No Abstract] [Full Text] [Related]
55. A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection.
Wenger NK
J Womens Health Gend Based Med; 2001 Apr; 10(3):257-60. PubMed ID: 11389785
[No Abstract] [Full Text] [Related]
56. Are national guidelines for total hip replacement in the UK reflected in practice?
Abraham A; Hajipour L; Innes AR; Phillips H; McCaskie AW
Ann R Coll Surg Engl; 2006 Mar; 88(2):108-15. PubMed ID: 16551395
[TBL] [Abstract][Full Text] [Related]
57. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
58. DVT prophylaxis: a lost art?
Clem JR
S D J Med; 2001 Jul; 54(7):251-2. PubMed ID: 11471326
[No Abstract] [Full Text] [Related]
59. Long-term success of endometrial resection: in everyday clinical practice, personal audit is more important than the knowledge of how the majority of surgeons perform.
Maouris P; Jamieson R
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):65-7. PubMed ID: 15089872
[TBL] [Abstract][Full Text] [Related]
60. Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.
Farmer RD; Lawrenson RA; Hambleton IR
Eur J Contracept Reprod Health Care; 1996; 1(1):31-7. PubMed ID: 9678135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
